Recent studies have demonstrated that AKR1C3 was overexpressed in various cancers such as breast cancer (33), prostate cancer (34, 35) and acute myeloid leukemia (AML) (36–38). The gene discussed is AKR1C3; the disease is acute myeloid leukemia.